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Aims Obesity is associated with the presence of coronary artery disease (CAD) risk factors and cardiovascular events. We
examined the relationship between body mass index (BMI) and the presence, extent, severity, and risk of CAD in
patients referred for coronary computed tomographic angiography (CCTA).
Methods and
results
We evaluated 13 874 patients from a prospective, international, multicentre registry of individuals without known
CAD undergoing CCTA. We compared risk factors, CAD findings, and risk of all-cause mortality and non-fatal myo-
cardial infarction (MI) amongst individuals with underweight (18.5–20.0 kg/m2), normal (20.1–24.9 kg/m2), over-
weight (25–29.9 kg/m2), and obese (≥30 kg/m2) BMI. The mean follow-up was 2.4+1.2 years with 143 deaths
and 193 MIs. Among underweight, normal weight, overweight, and obese individuals, there was increasing prevalence
of diabetes (7 vs.10% vs. 12 vs. 19%), hypertension (37 vs. 40% vs. 46 vs. 59%), and hyperlipidaemia (48 vs. 52% vs. 56
vs. 56%; P , 0.001 for trend). After multivariable adjustment, BMI was positively associated with the prevalence of
any CAD [odds ratio (OR) 1.25 per +5 kg/m2, 95% confidence interval (CI): 1.20–1.30, P , 0.001] and obstructive
(≥50% stenosis) CAD (OR: 1.13 per +5 kg/m2, 95% CI: 1.08–1.19, P , 0.001); a higher BMI was also associated with
an increased number of segments with plaque (+0.26 segments per +5 kg/m2, 95% CI: 0.22–0.30, P , 0.001). Larger
BMI categories were associated with an increase in all-cause mortality (P ¼ 0.004), but no difference in non-fatal MI.
After multivariable adjustment, a higher BMI was independently associated with increased risk of MI (hazards ratio:
1.28 per +5 kg/m2, 95% CI: 1.12–1.45, P , 0.001).
Conclusions Amongst patients with suspected CAD referred for CCTA, individuals with increased BMI have greater prevalence,
extent, and severity of CAD that is not fully explained by the presence of traditional risk factors. A higher BMI is
independently associated with increased risk of intermediate-term risk of myocardial infarction.
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Introduction
Obesity is an important public health issue, and the prevalence of
obesity is rapidly rising, with 32 and 34% of adults in the USA cur-
rently defined as overweight and obese, respectively. In prior
studies, obesity has been positively associated with coronary
artery disease (CAD) risk factors,1 as well as increased rates of in-
cident adverse coronary heart disease events.2 –8 While asymp-
tomatic obese individuals are observed to have an increased
prevalence of CAD as defined by the coronary artery calcium
score,9 the prevalence of obstructive CAD identified by non-
invasive CCTA as related to body mass index (BMI) has not
been established. To determine the relationship between BMI
and the angiographic prevalence, extent, severity, and risk of
CAD, we examined individuals within a prospective multicentre
international registry of patients undergoing coronary computed
tomographic angiography (CCTA) in a cohort of individuals under-
going non-invasive coronary angiography.
Methods
Design overview
The CONFIRM (COronary CT Angiography EvaluatioN For Clinical
Outcomes: An InteRnational Multicentre) registry is a dynamic open-
label, international, multicentre observational registry designed to pro-
spectively evaluate the associations between patient characteristics,
CCTA findings, and adverse events. The rationale and design of this
study has been previously reported.10 All sites had the approval of re-
spective institutional review boards, and were compliant with the
Health Insurance Portability and Accountability Act where applicable.
As per each individual institution’s policy, patient consent or a
waiver of informed consent was obtained at each site in keeping
with site-specific regulations. The study was consistent with the prin-
ciples of the Declaration of Helsinki.
Setting and participants
We examined a total of 16 291 patients who underwent CCTA at
seven centres in six countries (Canada, South Korea, USA, Germany,
Switzerland, and Italy) who were enrolled into the registry between
February 2003 and December 2009. Inclusion criteria for enrollment
in the registry included an age ≥18 years; a CCTA study performed
on a scanner with at least 64-detector rows; an interpretable CCTA
examination; a normal, overweight, or obese BMI; prospective data
collection for CAD risk factors; and enrollment sites with reported
BMI and available all-cause mortality and non-fatal myocardial infarc-
tion (MI) outcomes. Patients were referred for a variety of indications,
including evaluation of symptoms; potential signs of cardiac disease
such as abnormal resting or stress electrocardiographic tests; or
asymptomatic patients requiring preoperative evaluation, or with per-
ipheral arterial disease, congenital heart disease, cerebrovascular
disease, or multiple CAD risk factors.
The present study examined patients stratified by underweight BMI
(≤20.0 kg/m2), normal BMI (20.1–24.9 kg/m2), overweight BMI (25–
29.9 kg/m2), and obese BMI (≥30 kg/m2). Individuals with prior coron-
ary revascularization or MI, or with missing BMI or CCTA findings
were excluded. A total of 13 968 patients met these criteria; 94 indi-
viduals were lost to follow-up, resulting in 13 874 patients who were
evaluated in this study.
All CCTA performance, data acquisition, image post-processing, and
interpretation in the study cohort were consistent with the Society of
Cardiovascular Computed Tomography guidelines.11,12 All CCTA
studies were performed using a scanner with at least 64 detector
rows. Coronary artery calcium score (CACS) was assessed using the
Agatston score method as previously described.13 All scans were inter-
preted by a Level III-equivalent cardiologist or radiologist with the ex-
perience of interpreting several thousand CCTA examinations, using
uniform data elements with standardized definitions.
In each coronary artery, coronary atherosclerosis was defined as any
tissue structures ≥1 mm2 in size within or adjacent to the coronary
artery lumen that could be discriminated from surrounding pericardial
tissue, epicardial fat, or the vessel lumen itself. The luminal stenosis of
coronary atherosclerotic lesions was determined by visual estimation
in accordance with guidelines.12 CAD was defined as the presence
of any plaque, and was stratified as no CAD (no plaque), mild CAD
(maximal stenosis 1–49%), moderate CAD (maximal stenosis 50–
69%), and severe CAD (≥70% stenosis). Obstructive CAD was
defined as ≥50% luminal diameter stenosis. CAD was also assessed
by the segment involvement score and a segment stenosis score,
using a 16-segment model as previously described.14 The segment in-
volvement score is a measure of overall plaque distribution, and repre-
sents the number of segments with any plaque (range 0–16). The
segment stenosis score is a measure of overall coronary artery
plaque burden and severity, and grades each segment on scale of 0–
3 as having no, mild (1–49% stenosis), moderate (50–69% stenosis),
or severe (≥70% stenosis); each segment is added together for a
total score of 0–48.14,15
Outcomes and follow-up
The primary endpoints were mortality by any cause and non-fatal MI,
which were ascertained by a dedicated physician and/or research
nurse. All-cause mortality in the USA was obtained by query of the na-
tional death index. All-cause mortality in other countries and non-fatal
MI in all countries were obtained by direct patient interview; telephone
contact with the patient, the patient’s immediate family, or the patient’s
physician; or by the review of medical records as described.10
Statistical analysis
A post hoc power analysis was performed to determine the robustness
of the study sample size to discriminate the differences between
groups in the rate of obstructive CAD. Based on the study results,
the achieved one-tailed power at an alpha of 0.05 was 99.9%
between the normal and overweight BMI cohorts, and 99.9%
between the normal and obese BMI cohorts. Additional post hoc
power analyses were performed to delineate the adequacy of the
sample size to the achieved one-tailed power at an alpha of 0.05 to
identify the differences between death and non-fatal MI between
BMI groups. The achieved power for all-cause mortality was 0.78
between individuals with a normal and overweight BMI, and 0.95
between individuals with a normal and obese BMI. The achieved
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power for non-fatal MI was 0.93 for those with normal vs. overweight
BMI, and 0.99 for those with normal vs. obese BMI.
Comparisons were performed for a trend in increasing BMI categor-
ies defined as underweight BMI, normal BMI, overweight and obese
individuals. Categorical variables were compared using x2 tests for
trends across increasing BMI groups. Comparisons between continu-
ous variables with a normal distribution were performed by t-tests
and ANOVA with the Tukey post hoc test, while comparisons
between continuous variables with non-normal distributions were per-
formed by the Mann–Whitney U test.
To determine the independent relationship between CAD and BMI,
backwards stepwise logistic regression models considered variables
associated with the presence of any CAD and obstructive CAD; step-
wise linear regression models considered variables associated with
CAD assessed by the segment involvement score and segment sten-
osis score. We additionally evaluated this model using standardized
coefficients to assess the relative strength of the predictors.
Comparisons of adverse events were performed using log-rank tests
and Cox regression analyses to determine the relationship between
BMI and adverse events. For all multivariable analyses, considered vari-
ables included typical cardiovascular risk factors: age; gender; medical
history of hypertension, hyperlipidaemia, and diabetes; current
tobacco smoking; and BMI. Only variables with a univariate P , 0.10
were entered into the final model to prevent over-fitting of the
models. We additionally examined whether there were significant
interaction terms between BMI and other risk factors for prediction
of non-fatal MI and prediction of all-cause mortality; no significant
interaction terms were observed.
In exploratory analyses, we examined the risk of MI and prevalence
of CAD in specific subgroups defined by region (North America, Asia,
and Europe) and by ethnicity (Caucasian, Asian). All analyses were per-
formed using SPSS 19.0 (IBM, Somers, NY). Power analyses were per-
formed using PASS 11.0 (NCSS, Kaysville, UT, USA). A P , 0.05 was
considered statistically significant. There was no funding support for
this study.
Results
The overall mean (SD) age was 56.9 (11.8) years, 55.7% were male,
and the mean (SD) follow-up was 2.4 (1.2) years. The 13 874
patients in the study were stratified into those with underweight
BMI, normal BMI, overweight BMI, and obese BMI. There was a sig-
nificant trend in the increase in BMI and increased prevalence of
cardiovascular risk factors except smoking (Table 1). Amongst
the 12 826 individuals with known symptom status, chest pain
was present in 69.2, 65.4, 63.6, and 62.9% of individuals with under-
weight BMI, normal BMI, overweight BMI, and obese BMI, respect-
ively (P-value for trend ¼ 0.0045).
BMI and the presence of CAD
There were significant differences in patterns of CAD between
groups (Table 2). There was a significant increase in the prevalence
of any plaque as well as moderate and severe obstructive CAD for
increased BMI categorization. There was no difference in the
prevalence of left main obstructive CAD between the BMI
groups. There was a significant increase in the prevalence of ob-
structive CAD in each of the other epicardial coronary arteries;
a higher number of obstructive vessels; and increased extent and
severity as manifest by the segment involvement and segment sten-
osis scores.
After adjustment for CAD risk factors, an increased BMI was in-
dependently associated with an increased probability of any CAD
[odds ratio (OR): 1.25 per +5 kg/m2, 95% confidence interval
(CI): 1.20–1.30, P , 0.001) and obstructive CAD (OR: 1.13 per
+5 kg/m2, 95% CI: 1.08–1.19, P , 0.001) (Figure 1). Further,
multivariate analyses also determined that an increased BMI was in-
dependently associated with greater segment involvement scores
(+0.26 score per +5 kg/m2, 95% CI: 0.22–0.30, P , 0.001)
and higher segment stenosis scores (+0.30 score per +5 kg/m2,
95% CI: 0.24–0.37, P , 0.001).
We additionally examined a model using standardized coeffi-
cients to assess the relative strength of each of the predictors. In
this model, the adjusted variables most strongly associated with
the presence of CAD (from strongest to weakest) were increased
age (OR: 2.82, 95% CI: 2.69–2.96, P , 0.001), male gender (OR:
1.81, 95% CI: 1.75–1.90, P , 0.001), increased BMI (OR: 1.24,
95% CI: 1.19–1.29, P , 0.001), current smoking (OR: 1.18, 95%
CI: 1.14–1.23, P , 0.001), hyperlipidaemia (OR: 1.15, 95% CI:
1.11–1.20, P , 0.001), diabetes (OR: 1.14, 95% CI: 1.09–1.18,
P , 0.001), and hypertension (OR: 1.06, 95% CI: 1.02–1.10, P ¼
0.004).
BMI and adverse events
There were a total of 143 deaths and 193 non-fatal MIs during an
intermediate-term follow-up. Death and non-fatal MI occurred in
10 and 2 patients with underweight BMI, 50 and 44 patients with
a normal BMI, 53 and 83 overweight individuals, and 30 and 64
obese patients, respectively. While no significant differences
were observed between groups in non-fatal MIs (Figure 2A),
normal, overweight, and obese individuals had increased risks of
all-cause mortality (Figure 2B). For individuals with a BMI ,20.0,
20.0–24.9, 25.0–29.9, 30.0–34.9, and ≥35 kg/m2, the annualized
event rate for death was 1.2, 0.4, 0.4, 0.5, 0.4, and 0.4%, respective-
ly; while the annualized event rate for non-fatal MI was 0.3, 0.3, 0.5,
0.7, and 1.2%, respectively.
After adjustment for CAD risk factors and BMI, variables inde-
pendently associated with the risk of non-fatal MI included
smoking [hazards ratio (HR): 1.64, 95% CI: 1.15–2.33, P ¼ 0.006),
hypertension (HR: 1.42, 95% CI: 1.04–1.94, P ¼ 0.03), age
(HR: 1.47 per +10 years, 95% CI: 1.28–1.69, P , 0.001), diabetes
(HR: 1.51, 95% CI: 1.06–2.15, P ¼ 0.02), and BMI (HR: 1.28 per
+5 kg/m2, 95% CI: 1.12–1.45, P , 0.001); male gender (P ¼ 0.29)
and hyperlipidaemia (P ¼ 0.65) were not independently associated
with the risk of non-fatal MI.
Using a model with standardized coefficients to assess the rela-
tive strength of each of the predictors, the adjusted variables most
strongly associated with the risk of MI (from strongest to weakest),
were increased age (HR: 1.70, 95% CI: 1.41–2.04, P , 0.001),
higher BMI (HR: 1.32, 95% CI: 1.15–1.52, P , 0.001), hypertension
(HR: 1.23, 95% CI: 1.03–1.46, P ¼ 0.02), and current smoking (HR:
1.18, 95% CI: 1.02–1.37, P ¼ 0.03).
After adjustment for CAD risk factors, a normal vs. elevated BMI
(,25 vs. ≥25 kg/m2, P ¼ 0.69) and an obese vs. non-obese BMI
(,30 vs. ≥30 kg/m2, P ¼ 0.27) were not associated with the risk
of all-cause mortality.
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Table 1 Patient demographics and medical history by body mass index
Underweight










Age (years) 55.6 (13.4) 57.7 (12.0) 57.2 (11.4) 55.3 (11.8)* ,0.0001 Underweight vs. normal, P ¼ 0.0065;
normal vs. obese, P , 0.0001;
overweight vs. obese, P , 0.0001
Male gender (%) 24.6 50.1 63.0 53.7 ,0.0001
Diabetes (%) 6.6 9.8 12.0 18.7* ,0.0001
Hypertension (%) 37.1 39.8 46.2 58.8* ,0.0001
Hyperlipidaemia
(%)
48.2 52.3 55.6 55.7* 0.0002
Smoking (%) 22.0 16.5 16.3 16.8 0.4500
BMI (kg/m2) 19.5 (0.4) 23.1 (1.3) 27.1 (1.4) 34.2 (4.5)* ,0.0001 All groups significantly different,
P , 0.0001 for all
Values are provided as the mean (standard deviation) or percentage. BMI, body mass index.
*P , 0.01 between the three groups.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Coronary artery findings by body mass index
Underweight













162.2 (571.8) 115.1 (345.8) 137.3 (384.0) 176.3 (469.0) ,0.0001 Normal vs. overweight, P ¼ 0.0481;
Normal vs. obese, P , 0.0001;
Overweight vs. obese,
P ¼ 0.0003
CAD stenosis severity (%)
Any plaque 34.9 49.2 57.0 57.7 ,0.0001
≥Moderate
(≥50%)
11.4 15.9 20.6 20.7 ,0.0001
≥Severe
(≥70%)
2.9 7.7 10.2 11.2 ,0.0001
Obstructive CAD by artery (%)
Left main 0.9 1.0 1.1 1.1 0.6029
Left anterior
descending
5.6 12.1 15.4 15.5 ,0.0001
Left circumflex 2.7 5.2 7.2 6.8 ,0.0001
Right coronary 5.0 6.6 8.9 9.6 ,0.0001
Vessels with obstructive CAD (%) ,0.0001
One 8.9 9.9 12.4 12.4
Two 1.8 3.8 5.4 5.5
Three 0.3 2.0 2.7 2.8




0 (0–1) 0 (0–2) 1 (0–3) 1 (0–4) ,0.0001 All groups significantly different,




0 (0–1) 0 (0–3) 1 (0–4) 1 (0–5) ,0.0001 All groups significantly different,
P , 0.04 for all
Values are provided as the mean (standard deviation) for calcium score, median (interquartile range) for CAD severity and extent grades or percentage. Obstructive CAD defined
as a diameter stenosis ≥50%. BMI, body mass index; CAD, coronary artery disease.
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Relationship of BMI with CAD as
stratified by geographical location
and ethnicity
We performed subgroup analyses to determine whether there
were potential differences in results between regions, and com-
pared patients from North America (n ¼ 6087), Europe (n ¼
3922), and Asia (n ¼ 3865). After adjustment for risk factors and
BMI, an increased BMI was independently associated with the pres-
ence of any CAD amongst individuals in North America (OR: 1.11
per +5 kg/m2, 95% CI: 1.05–1.17, P , 0.001), with no significant
relationship observed amongst individuals in Europe (OR: 1.08
per +5 kg/m2, 95% CI: 0.98–1.17, P ¼ 0.15) or Asia (OR: 1.13
per +5 kg/m2, 95% CI: 0.99–1.28, P ¼ 0.07). For these subgroups,
there were no significant differences observed between BMI and
adjusted risk of non-fatal MI (P ¼ 0.79, 0.91, and 0.50 for North
America, Europe, and Korea, respectively).
We performed additional subgroup analyses to determine
whether there were differences in findings between ethnic
groups. Ethnicity information was available in 10 205 individuals;
amongst these individuals, 5699 were Caucasian, 3880 were
Asian, and the remaining 626 patients represented other ethnicities.
An increased BMI was independently associated with a greater
prevalence of any CAD in Caucasian (OR: 1.15 per +5 kg/m2,
95% CI: 1.08–1.22, P , 0.001) and Asian patients (OR: 1.22 per
+5 kg/m2, 95% CI: 1.08–1.39, P ¼ 0.002), with no significant differ-
ence observed in the remaining ethnicity groups combined (OR:
1.13 per +5 kg/m2, 95% CI: 0.96–1.33, P ¼ 0.15). For the larger
subgroups, there were no significant differences observed
between BMI and adjusted risk of non-fatal MI (P ¼ 0.16 and 0.60
for Caucasian and Asian individuals, respectively).’
Discussion
The results of this prospective multicentre international study
demonstrate a strong and consistent relationship between an
increased BMI and the prevalence, extent and severity of CAD.
Further, we determined that a greater BMI was significantly
related to incident risk of non-fatal MIs, although no significant re-
lationship was observed between BMI and all-cause mortality
during the intermediate-term follow-up of the study. Finally, we
observed that the increased rates of CAD and risk of non-fatal
MI were independently associated with a higher BMI in a manner
that was not fully explained by the co-existence of traditional
CAD risk factors alone.
The present findings may serve to clarify the relationship
between BMI and non-invasive measures of CAD as previously
examined in prior studies. As an example, a substudy of 6814 indi-
viduals from the low-risk Multi-Ethnic Study of Atherosclerosis
(MESA) population aged 45–84 years observed that obese indivi-
duals had an increased risk of CAD as measured by coronary
artery calcification score.16 In a cohort referred for invasive coron-
ary angiography, Rubinshtein et al.17 evaluated 928 patients, and
reported that obese individuals were less likely to have three-
vessel or left main disease, although there was a significant de-
crease in age with increasing BMI, which ranged from a mean age
of 71–59 years for those with a BMI ,21 and ≥35 kg/m2, respect-
ively. Another study examined 770 patients referred for invasive
coronary angiography and observed negative correlations
between BMI and CAD burden as well as BMI and age, suggesting
a potential referral bias in which that individuals with a higher BMI
were referred for invasive angiography at a younger age, which may
have explained the lower extent and severity of CAD.18 The
present data extend those from prior studies by examining a dis-
tinct population of patients referred for non-invasive diagnostic
imaging by CCTA who would be expected to be at higher risk
of CAD than population-based cohorts tested by calcium
scoring, and at lower risk of CAD than individuals referred for in-
vasive procedures. This is reflected in the intermediate observed
prevalence of obstructive CAD (20%) by CCTA in the present
study, and the present findings are most consistent with those
reported in the MESA population, as the present study identifies
Figure 1 Variables independently associated with the presence of any CAD and obstructive CAD. These represent the adjusted odds ratios
(boxes) and 95% confidence intervals (horizontal lines) for each of the risk factors in the models. An increased BMI (per +5 kg/m2) was in-
dependently associated with a greater presence of any CAD (P , 0.001) and obstructive CAD (P , 0.001). Obstructive CAD is defined as the
presence of any stenosis ≥50% in diameter. BMI, body mass index; CAD, coronary artery disease.
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significant increases in CAD by both CCTA and CACS measures in
patients with an increased BMI. When we examined subgroups by
region or by ethnicity, we did not observe significant differences in
all of the ethnic groups and regions. This may be due to inadequate
power for these subgroup analyses, or may be a result of inherent
differences between groups; future larger studies may be
Figure 2 (A) Kaplan–Meier survival plot for non-fatal myocardial infarction and (B) all-cause mortality.
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warranted to better evaluate these findings across regions and
ethnic groups.
Prior population-based studies including the Framingham Heart
Study, Nurses Health Study, Physicians’ Health Study, Women’s
Health Study, and Interheart Study have observed increased mor-
tality and/or adverse cardiac events in overweight and/or obese
individuals,2– 7 findings were consistent with a recent
meta-analysis.8 Further, a recent study of over 1 million Asian indi-
viduals observed increased mortality in East Asians with an ele-
vated BMI, although no differences were observed in South
Asian individuals.19 The findings contrast with observations in
patients with known obstructive CAD; a recent meta-analysis of
40 studies including over 250 000 patients with known CAD
reported that overweight patients had the lowest rates of all-cause
mortality, with no difference in mortality seen in obese patients.20
Further, a study of 16 816 patients referred for myocardial perfu-
sion single-photon emission computed tomography observed
that the BMI of patients with suspected but not known CAD
was not independently associated with the risk of cardiac death,
while individuals with known obstructive CAD were observed to
have an inverse relationship between BMI and the risk of cardiac
death.21
We examined patients with suspected CAD referred for non-
invasive diagnostic imaging by CCTA, while excluding individuals
with established obstructive CAD. Our results suggest that an
increased BMI is associated with a significantly increased risk of
non-fatal MIs in a population without known CAD referred for
non-invasive diagnostic testing, even during the relatively short
follow-up time of the study. These findings are consistent with
the observed increase in the prevalence, extent, and severity of
CAD by CCTA in larger individuals, which may be expected to
be associated with an increased risk of adverse events.22 While
no significant relationship was observed between BMI and non-
fatal MI in subgroups by region and ethnicity, it is expected that
this may be due to inadequate power in these smaller cohorts,
as the overall study population only had 80% power to determine
a relationship between BMI and risk of this event.
We did not observe a significant relationship between BMI and
all-cause mortality. While the study was underpowered for com-
parisons between normal and overweight individuals, it did have
adequate power between normal and obese individuals on post
hoc analysis. The lack of a significant difference may be related to
the relatively short period of follow-up. While a large collaborative
analysis of nearly 900 000 adults from 57 prospective studies
demonstrated an increase in long-term all-cause mortality
between individuals with normal and increasing BMI, the study
excluded the initial 5 years of follow-up, and reported events
only during a subsequent mean follow-up of 8 years.8 In contrast,
the current study examined only events during a intermediate-
term follow-up after the CCTA study (mean of 2.4 years), and
cannot determine the risk of longer-term mortality.
Of note, the relationship between BMI, other cardiovascular risk
factors, and the prevalence and risk of CAD are complex. Obesity
and/or an increased BMI are independently associated with greater
risk of insulin resistance, metabolic syndrome, diabetes, hyperten-
sion, and dyslipidaemia, and data suggest that the presence of these
comorbidities may be more important markers of CAD risk than
obesity alone.23 –26 Further, there is increasing evidence of a rela-
tionship between obesity and systemic inflammation, including an
increased production of inflammatory factors such as leptin,
tumor necrosis factor-a, interleukin-6, and resistin, as well as
decreased production of adiponectin.27,28
One limitation of the present study is that it assessed risk factors
as present or absent based on patient-reported history and pre-
scribed medications, and did not confirm these diagnoses from
physician records or laboratory testing at the point of service.
The present study could not assess the severity of risk factors
such as hypertension and diabetes, did not examine all potential
covariates (such as metabolic syndrome or insulin resistance),
did not evaluate the duration and treatment of risk factors, and
did not obtain specific variables such as blood pressure, and inflam-
matory markers. Future prospective trials assessing these variables
may be warranted to improve our understanding of the relation-
ship between BMI and the prevalence, patterns, and risk of CAD.
This study has additional limitations. BMI may be an imperfect
method to identify abdominal and visceral fat, as it does not distin-
guish lean and adipose tissue, and visceral fat (including epicardial
fat) has been associated with increased CAD burden and risk of
adverse events.29,30 Nevertheless, while waist-to-height ratio is
observed to have the best model fit to identify risk of cardiovascu-
lar events, the difference between this measure and BMI has been
reported to be of minor clinical significance.5 We employed BMI,
as this is the most commonly employed metric for assessing
obesity and may be easily determined, permitting these results to
be maximally generalizable. Further, while CCTA has been demon-
strated to have high diagnostic performance to identify obstructive
CAD, it can be associated with false-positive results31– 33 and may
overestimate the prevalence of obstructive CAD. In addition, due
to the anatomic detail provided by CT images, readers were not
blinded to the patient’s body habitus. Finally, the study evaluated
only intermediate-term events during a mean follow-up of
2.4 years, and the risk of events over a longer period cannot be
determined. While we demonstrated adequate power for risk of
non-fatal MI, we did not have adequate power for risk of all-cause
mortality, and as such, the latter should be considered exploratory.
In this prospective multicentre study of patients referred for
non-invasive coronary imaging, overweight and obese individuals
possess a greater prevalence, extent, and severity of CAD that
does not appear to be entirely explained by the presence or
absence of traditional risk factors alone. Further, a higher BMI is in-
dependently associated with an increased risk of intermediate-term
non-fatal MI.
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